查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1939210

2026年全球α輻射源市場報告

Alpha Emitter Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，α放射性核種市場呈指數級成長，預計將從2025年的16.1億美元成長到2026年的19.9億美元，複合年成長率達23.6%。迄今為止的成長可歸因於多種因素，包括α放射性核素供應有限、對鈾和鐳等天然資源的依賴、人們對標靶癌症治療的認知不斷提高、早期臨床試驗的出現以及生產基礎設施的缺乏。

預計未來幾年，α發射體市場將呈指數級成長，到2030年市場規模將達到46億美元，複合年成長率（CAGR）為23.3%。預測期內的成長要素包括人工放射性核種生產設施的建設、腫瘤治療投資的增加、骨轉移和前列腺癌治療中α發射體應用的日益普及、靶向α療法技術的進步以及在醫學研究領域應用的不斷拓展。預測期內的主要趨勢包括α發射體在治療方法中的應用日益廣泛、放射性核素生產和分離研究的不斷深入、人工生產的α發射體數量的成長、α發射體在腫瘤治療領域之外的治療應用拓展，以及對放射性物質處理安全性和合規性的日益重視。

預計未來幾年癌症發生率的上升將推動α發射體市場的成長。癌症是一種異常細胞在體內不受控制地生長和擴散，形成腫瘤並侵襲周圍組織的疾病。導致癌症發生率上升的因素包括人口老化、環境暴露、生活方式改變以及檢測方法的進步。 α發射體用於癌症治療，能夠精準靶向並摧毀癌細胞，同時最大限度地減少對周圍正常組織的損傷。例如，總部位於瑞士的國際組織－世界衛生組織（WHO）於2024年2月預測，2050年，全球將新增超過3,500萬例癌症病例，比2022年估計的2,000萬例成長77%。因此，癌症發生率的上升正在推動α發射體市場的成長。

為了增強自身競爭優勢，α放射性核種市場的企業正在投資創新解決方案，例如迴旋加速器生產的α放射性核種。迴旋加速器產生的α放射性核素是崩壞時會釋放α粒子的放射性同位素，其生產方法是在迴旋加速器中將帶電粒子加速到高能量。例如，2023年4月，總部位於美國的迴旋加速器和科技公司Ionetix在其位於密西根州蘭辛市的新建α同位素生產設施中成功生產了首個α放射性核種－砹-211（At-211）。該設施是美國第一個專門利用迴旋加速器技術生產α放射性核種的設施。透過調試一台 30 MeV 迴旋加速器，實現了高產率的砹-211 (At-211) 和錒-225 (試運行-225) 的生產。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球α輻射源市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 擴大α粒子發射體癌症治療方法的應用
    • 加強對放射性核種生產與分離的研究力度
    • 人工產生的α發射體增加
    • 拓展腫瘤學以外的應用
    • 更重視放射性物質處理過程中的安全與法規遵循

第5章 終端用戶產業市場分析

  • 醫院
  • 醫學研究所
  • 腫瘤診所
  • 製藥公司
  • 核子醫學檢查室

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球α輻射源市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球α輻射源市場規模、比較及成長率分析
  • 全球α輻射源市場表現：規模與成長，2020-2025年
  • 全球α輻射源市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按放射性核種類型
  • 鐳、錒、鉛、鉍和其他放射性核種
  • 按來源
  • 天然的、人工生產的和其他來源
  • 透過使用
  • 胰臟癌、卵巢癌、攝護腺癌、淋巴瘤、黑色素瘤、骨轉移及其他適應症
  • 最終用戶
  • 醫院、醫學研究機構和其他最終用戶
  • 按類型細分：鐳
  • 鐳-223、鐳-226、鐳-228
  • 按類型細分：錒系元素
  • 錒-227，錒-225
  • 按類型細分：潛在客戶
  • 鉛-210，鉛-212
  • 按類型細分：鉍
  • 鉍-213，鉍-212
  • 按類型細分：其他放射性核素
  • 釷、釙、鍅

第10章 區域與國家分析

  • 全球α輻射源市場：依地區、性能及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球α輻射源市場：依國家分類，實際結果及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • α射線源市場：競爭格局及市場佔有率（2024年）
  • α輻射源市場：公司估值矩陣
  • α輻射源市場：公司概況
    • Bayer AG
    • Lantheus Holdings Inc.
    • Curium Pharma
    • Eckert & Ziegler BEBIG GmbH
    • Telix Pharmaceuticals Limited

第37章：其他領先和創新企業

  • NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年α輻射源市場：提供新機會的國家
  • 2030年α輻射源市場：蘊藏新機會的細分市場
  • 2030年α輻射源市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MAEMI02_G26Q1

An alpha emitter is a form of radioactive material that releases alpha particles during radioactive decay. It includes elements such as uranium, radium, and plutonium, which undergo alpha decay as part of natural radioactive processes. Alpha emitters are important in medical treatments, particularly cancer therapy, and have applications in technologies like smoke detectors and space exploration.

The main radionuclides of alpha emitters include radium, actinium, lead, bismuth, and others. Radium is a radioactive substance used in both therapeutic and diagnostic medical procedures. The sources include natural origins, artificially produced sources, and others, while the applications include pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. They are used across various end-users such as hospitals, medical research organizations, and others.

Tariffs have influenced the alpha emitter market by increasing costs for imported radionuclides and production equipment, particularly affecting segments like radium-223, actinium-225, and bismuth-213. Asia-Pacific regions, including China and India, are highly impacted due to import dependencies. While tariffs raise production costs and may slow supply chains, they also incentivize local production, research investment, and development of alternative radionuclide sources, supporting long-term market growth.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.61 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to limited availability of alpha-emitting radionuclides, reliance on natural sources like uranium and radium, growing awareness of targeted cancer therapies, emergence of early clinical trials, limited production infrastructure.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to development of artificial radionuclide production facilities, rising investment in oncology treatments, increasing adoption in bone metastasis and prostate cancer therapies, advancement in targeted alpha therapy technologies, expanding medical research applications. Major trends in the forecast period include rising adoption of alpha-emitter-based cancer therapies, increased research in radionuclide production and isolation, growth in artificially produced alpha emitters, expansion of therapeutic applications beyond oncology, enhanced focus on safety and regulatory compliance for handling radioactive materials.

The growing prevalence of cancer is expected to drive the growth of the alpha emitter market in the coming years. Cancer is a disease characterized by the uncontrolled proliferation and spread of abnormal cells within the body, which can form tumors and invade surrounding tissues. The increasing prevalence of cancer is influenced by factors such as aging populations, environmental exposure, lifestyle changes, and advancements in detection methods. Alpha emitters are used in cancer therapy to precisely target and destroy tumor cells while minimizing damage to nearby healthy tissues. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there will be more than 35 million new cancer cases worldwide, representing a 77% increase compared with the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the alpha emitter market.

Companies operating in the alpha-emitter market are investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to strengthen their competitive positioning. Alpha-emitting radionuclides generated using cyclotrons are radioactive isotopes that emit alpha particles during decay, produced by accelerating charged particles to high energies within a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable for being the first in the US dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. Production was achieved through the commissioning of a 30 MeV cyclotron designed to accelerate alpha particles for high-yield generation of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. With this acquisition, Bristol-Myers Squibb Co. enhances its oncology portfolio by adding innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio Inc. is a US-based provider of alpha-emitter technologies.

Major companies operating in the alpha emitter market are Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics, Oncoinvent ASA, Theragnostics Ltd., ARICEUM Therapeutics, Sirius Medical Systems B.V.

North America was the largest region in the alpha emitter market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
  • 2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
  • 3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
  • 4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
  • Subsegments:
  • 1) By Radium: Radium-223; Radium-226; Radium-228
  • 2) By Actinium: Actinium-227; Actinium-225
  • 3) By Lead: Lead-210; Lead-212
  • 4) By Bismuth: Bismuth-213; Bismuth-212
  • 5) By Other Types of Radionuclides: Thorium; Polonium; Francium
  • Companies Mentioned: Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH; Telix Pharmaceuticals Limited; NorthStar Medical Radioisotopes LLC; ITM Isotope Technologies Munich SE; International Isotopes Inc.; IBA Radiopharma Solutions; Orano Med LLC; Actinium Pharmaceuticals Inc.; Clarity Pharmaceuticals Ltd.; RadioMedix Inc.; Nordic Nanovector ASA; TAE Life Sciences; Fusion Pharmaceuticals Inc.; Alpha Tau Medical Ltd.; Alpha-9 Oncology; Aktis Oncology; Abdera Therapeutics; Oncoinvent ASA; Theragnostics Ltd.; ARICEUM Therapeutics; Sirius Medical Systems B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Alpha Emitter Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Alpha Emitter Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Alpha Emitter Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Alpha Emitter Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Alpha-Emitter-Based Cancer Therapies
    • 4.2.2 Increased Research In Radionuclide Production And Isolation
    • 4.2.3 Growth In Artificially Produced Alpha Emitters
    • 4.2.4 Expansion Of Therapeutic Applications Beyond Oncology
    • 4.2.5 Enhanced Focus On Safety And Regulatory Compliance For Handling Radioactive Materials

5. Alpha Emitter Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Medical Research Institutions
  • 5.3 Oncology Clinics
  • 5.4 Pharmaceutical Companies
  • 5.5 Nuclear Medicine Laboratories

6. Alpha Emitter Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Alpha Emitter Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Alpha Emitter PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Alpha Emitter Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Alpha Emitter Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Alpha Emitter Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Alpha Emitter Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Alpha Emitter Market Segmentation

  • 9.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radium, Actinium, Lead, Bismuth, Other Types Of Radionuclides
  • 9.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Natural Sources, Artificially Produced Sources, Other Sources
  • 9.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Lymphoma, Melanoma, Bone Metastasis, Other Applications
  • 9.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Medical Research Institutions, Other End-Users
  • 9.5. Global Alpha Emitter Market, Sub-Segmentation Of Radium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radium-223, Radium-226, Radium-228
  • 9.6. Global Alpha Emitter Market, Sub-Segmentation Of Actinium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Actinium-227, Actinium-225
  • 9.7. Global Alpha Emitter Market, Sub-Segmentation Of Lead, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lead-210, Lead-212
  • 9.8. Global Alpha Emitter Market, Sub-Segmentation Of Bismuth, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bismuth-213, Bismuth-212
  • 9.9. Global Alpha Emitter Market, Sub-Segmentation Of Other Types Of Radionuclides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Thorium, Polonium, Francium

10. Alpha Emitter Market Regional And Country Analysis

  • 10.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Alpha Emitter Market

  • 11.1. Asia-Pacific Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Alpha Emitter Market

  • 12.1. China Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Alpha Emitter Market

  • 13.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Alpha Emitter Market

  • 14.1. Japan Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Alpha Emitter Market

  • 15.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Alpha Emitter Market

  • 16.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Alpha Emitter Market

  • 17.1. South Korea Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Alpha Emitter Market

  • 18.1. Taiwan Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Alpha Emitter Market

  • 19.1. South East Asia Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Alpha Emitter Market

  • 20.1. Western Europe Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Alpha Emitter Market

  • 21.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Alpha Emitter Market

  • 22.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Alpha Emitter Market

  • 23.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Alpha Emitter Market

  • 24.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Alpha Emitter Market

  • 25.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Alpha Emitter Market

  • 26.1. Eastern Europe Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Alpha Emitter Market

  • 27.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Alpha Emitter Market

  • 28.1. North America Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Alpha Emitter Market

  • 29.1. USA Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Alpha Emitter Market

  • 30.1. Canada Alpha Emitter Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Alpha Emitter Market

  • 31.1. South America Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Alpha Emitter Market

  • 32.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Alpha Emitter Market

  • 33.1. Middle East Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Alpha Emitter Market

  • 34.1. Africa Alpha Emitter Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Alpha Emitter Market Regulatory and Investment Landscape

36. Alpha Emitter Market Competitive Landscape And Company Profiles

  • 36.1. Alpha Emitter Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Alpha Emitter Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Alpha Emitter Market Company Profiles
    • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Telix Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

37. Alpha Emitter Market Other Major And Innovative Companies

  • NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, TAE Life Sciences, Fusion Pharmaceuticals Inc., Alpha Tau Medical Ltd., Alpha-9 Oncology, Aktis Oncology, Abdera Therapeutics

38. Global Alpha Emitter Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Alpha Emitter Market

40. Alpha Emitter Market High Potential Countries, Segments and Strategies

  • 40.1 Alpha Emitter Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Alpha Emitter Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Alpha Emitter Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer